SELLAS Life Sciences Announces Review of Strategic Alternatives

NEXT STORY
Exagen and the Lupus Foundation of America Partner on New Initiative to Reduce the Time to an Accurate Lupus Diagnosis
PREV STORY
electroCore Announces Positive Coverage Policies of gammaCore Issued by Highmark
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rexahn Pharmaceuticals Announces Clinical Collaboration with Merck to Evaluate RX-5902 (Supinoxin™) in combination with KEYTRUDA® (pembrolizumab) for Triple Negative Breast Cancer

ROCKVILLE, Md. , Aug. 21, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), ...

author_avatar
NASDAQ Market News

Victoza® significantly reduced the risk of major cardiovascular events and death in adults with type 2 diabetes in the LEADER trial

New Orleans, US, 13 June 2016 - Novo Nordisk today announced that Victoza® (liraglutide) significantly ...

author_avatar
NASDAQ Market News

EDAP’s Ablatherm® Robotic HIFU Treats First Patient at Henry Ford Hospital in Detroit

LYON, France, Aug. 22, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader ...

author_avatar
NASDAQ Market News